ARTICLE | Company News
AMEV, MedImmune optimization deal
September 18, 2001 7:00 AM UTC
Applied Molecular Evolution (AMEV) will use its AMEsystem directed molecular evolution technology to optimize an anti- interleukin-9 (IL-9) antibody for MEDI under the companies' 1999 alliance. IL-9 i...